FOLD
Price
$7.91
Change
+$0.18 (+2.33%)
Updated
Sep 16, 12:21 PM (EDT)
Capitalization
2.38B
50 days until earnings call
PCVX
Price
$31.07
Change
+$0.07 (+0.23%)
Updated
Sep 16, 12:34 PM (EDT)
Capitalization
4.02B
55 days until earnings call
Interact to see
Advertisement

FOLD vs PCVX

Header iconFOLD vs PCVX Comparison
Open Charts FOLD vs PCVXBanner chart's image
Amicus Therapeutics
Price$7.91
Change+$0.18 (+2.33%)
Volume$1.61K
Capitalization2.38B
Vaxcyte
Price$31.07
Change+$0.07 (+0.23%)
Volume$3.86K
Capitalization4.02B
FOLD vs PCVX Comparison Chart in %
Loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FOLD vs. PCVX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Buy and PCVX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (FOLD: $7.73 vs. PCVX: $31.00)
Brand notoriety: FOLD and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 86% vs. PCVX: 94%
Market capitalization -- FOLD: $2.38B vs. PCVX: $4.02B
FOLD [@Biotechnology] is valued at $2.38B. PCVX’s [@Biotechnology] market capitalization is $4.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 2 TA indicator(s) are bullish while PCVX’s TA Score has 5 bullish TA indicator(s).

  • FOLD’s TA Score: 2 bullish, 5 bearish.
  • PCVX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than FOLD.

Price Growth

FOLD (@Biotechnology) experienced а -3.13% price change this week, while PCVX (@Biotechnology) price change was -4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.47%. For the same industry, the average monthly price growth was +7.07%, and the average quarterly price growth was +34.59%.

Reported Earning Dates

FOLD is expected to report earnings on Nov 05, 2025.

PCVX is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+3.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.03B) has a higher market cap than FOLD($2.38B). FOLD YTD gains are higher at: -17.941 vs. PCVX (-62.130). FOLD has higher annual earnings (EBITDA): 33.1M vs. PCVX (-584.35M). PCVX has more cash in the bank: 1.66B vs. FOLD (231M). PCVX has less debt than FOLD: PCVX (85.8M) vs FOLD (443M). FOLD has higher revenues than PCVX: FOLD (571M) vs PCVX (0).
FOLDPCVXFOLD / PCVX
Capitalization2.38B4.03B59%
EBITDA33.1M-584.35M-6%
Gain YTD-17.941-62.13029%
P/E RatioN/AN/A-
Revenue571M0-
Total Cash231M1.66B14%
Total Debt443M85.8M516%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDPCVX
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
70%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BOGSX8.21N/A
N/A
Black Oak Emerging Technology
RMYYX10.16N/A
N/A
Russell Inv Multi-Strategy Income Y
PAFDX37.39N/A
N/A
T. Rowe Price Equity Income Advisor
MMUJX24.73N/A
N/A
MFS Utilities R4
PGLRX18.16N/A
N/A
Putnam Focused International Equity R

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-3.25%
VCYT - FOLD
43%
Loosely correlated
+3.21%
ATXS - FOLD
42%
Loosely correlated
-0.81%
IRON - FOLD
40%
Loosely correlated
+0.13%
SYRE - FOLD
40%
Loosely correlated
-5.18%
ROIV - FOLD
40%
Loosely correlated
-0.92%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-3.64%
KYMR - PCVX
46%
Loosely correlated
+0.62%
BEAM - PCVX
46%
Loosely correlated
+3.30%
TSHA - PCVX
45%
Loosely correlated
-1.63%
SYRE - PCVX
45%
Loosely correlated
-5.18%
IDYA - PCVX
44%
Loosely correlated
-0.33%
More